Pacira BioSciences, Inc. — Director's Dealing 2012

Mar 29, 2012

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Pacira Pharmaceuticals, Inc. (PCRX)
CIK: 0001396814
Period of Report: 2012-03-21

Reporting Person: Riker Lauren Bullaro (Executive Director, Accounting)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2000	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee Stock Option (right to buy)	$10.34	2021-05-10	Common Stock (40000)		Direct

Footnotes

F1: The stock option vests as follows: 25% of the shares shall vest on the one-year anniversary of the Vesting Commencement Date of May 2, 2011; 1/36th of the shares shall vest over the three year period thereafter.